BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24170076)

  • 1. [Ethical and theoretical medical comments on the desire and reality of individualised medicine].
    Paul NW; Mitzkat A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1473-9. PubMed ID: 24170076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ETHICS, MORALS AND SOCIETY IN PERSONALIZED MEDICINE].
    Flugelman A
    Harefuah; 2015 Sep; 154(9):599-603, 606. PubMed ID: 26665754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-focusing the ethical discourse on personalized medicine: a qualitative interview study with stakeholders in the German healthcare system.
    Schleidgen S; Marckmann G
    BMC Med Ethics; 2013 May; 14():20. PubMed ID: 23705623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalised medicine: a critique on the future of health care.
    Savard J
    J Bioeth Inq; 2013 Jun; 10(2):197-203. PubMed ID: 23515958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications.
    Norbert PW; Roses AD
    J Mol Med (Berl); 2003 Mar; 81(3):135-40. PubMed ID: 12755119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ethical, Legal and Regulatory Issues Associated with Pharmacogenomics: Systematically Quantifying the Literature.
    Hewitt JE
    J Law Med; 2018 Apr; 25(3):782-793. PubMed ID: 29978667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Individualisation of medicine: medical philosophy and societal implications of an ambiguous guiding principle].
    Kollek R
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):40-5. PubMed ID: 22325106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics - therapeutic and ethical issues.
    Patowary S
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Criteria for an ethically adequate prioritisation of individualised treatment strategies].
    Schleidgen S; Marckmann G
    Gesundheitswesen; 2014 Nov; 76(11):e57-64. PubMed ID: 25350389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics and personalized medicine: wicked problems, ragged edges and ethical precipices.
    Fleck LM
    N Biotechnol; 2012 Sep; 29(6):757-68. PubMed ID: 22433081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The lost art of abstaining: a consequence of industrialized health care].
    Maio G
    Dtsch Med Wochenschr; 2015 Jun; 140(13):1014-8. PubMed ID: 26115138
    [No Abstract]   [Full Text] [Related]  

  • 15. Implementing Precision Medicine: The Ethical Challenges.
    Korngiebel DM; Thummel KE; Burke W
    Trends Pharmacol Sci; 2017 Jan; 38(1):8-14. PubMed ID: 27939182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics--legal, ethical and regulatory considerations.
    March R; Cheeseman K; Doherty M
    Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Organizing health care: an ethical perspective].
    Grupo de Estudios de Ética Clínica, Sociedad Médica de Santiago
    Rev Med Chil; 2013 Jun; 141(6):780-6. PubMed ID: 24121582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race, distributive justice and the promise of pharmacogenomics: ethical considerations.
    Lee SS
    Am J Pharmacogenomics; 2003; 3(6):385-92. PubMed ID: 14672519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision medicine: what's all the fuss about?
    Barker R
    Scand J Clin Lab Invest Suppl; 2016; 245():S2-5. PubMed ID: 27542001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ethical analysis of the decision-making process in occupational health practice].
    Franco G
    Med Lav; 2005; 96(5):375-82. PubMed ID: 16711638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.